March 18, 2026
Vanderbilt Center for Cognitive Medicine enrolls first Down syndrome participant for Alzheimer’s disease study
Evan Dewey and his family travel from Atlanta to participate in the ABATE study, a clinical trial evaluating a treatment that could reduce the likelihood of Alzheimer’s disease development in individuals with Down syndrome
By Danny Bonvissuto